Objective-To see whether changes in prescribing of oral antibacterials in Northern Ireland show the need for a community antibiotics policy.
Introduction
It has been claimed that antibiotics are used indiscriminately,' are prescribed for problems for which they are ineffective,4" and are promoted in a way that may create unrealistic expectations for both the consumer and the prescriber.
In hospital practice the need for an antibiotic prescribing policy is well established and policies exist in many hospitals."8 Policies generally offer guidance ranging from those antibiotics which may be freely prescribed to those which are subject to varying degrees ofrestriction, and from rigid written policies to those promulgated informally by word of mouth. Their function is to encourage the safe, effective, rational, and economic use of antibiotics.
Two major developments in particular have indicated a need for an antibiotic prescribing policy in general practice. Firstly, there are an increasing number and variety of antibiotics being produced which often have no clear cut clinical advantage over those already available. In addition, potent broad spectrum antibiotics initially directed towards hospital use-for example, the quinolones-are now available in oral form and are being promoted for use in the community. Secondly, with increasing financial pressure on the health service the value of a drug must be assessed against its competitors by price as well as The agents studied were assigned to a "common" or "occasional" category based on their usage in 1983. Antimicrobials whose individual usage did not exceed 2% of the total were defined as occasional. All others studied were defined as common.
More detailed monthly totals were obtained for pivampicillin and ciprofloxacin to investigate the changes occurring at specific times in their commercial history. The usage of pivampicillin was surveyed monthly for 15 months after its launch in 1982 and again four years later. Prescriptions of ciprofloxacin BMJ VOLUME 300were monitored for the first 18 months after its launch in 1987.
Results
The annual number of prescriptions for antimicrobials remained fairly constant over the five years ( fig 1) . The number of dosing units of common agents (fig 2) and occasional agents ( fig 3) showed a direct correlation with the numbers of prescriptions written (r=0-996 and 0-994 respectively). Over the five years the two Cost ofa day's treatment with "common" and "occasional" agents Cost (£) social and psychological history "significantly affects" whether the general practitioner prescribes antibiotics or not.'5'6 Thus probability and the doctor-patient interaction may be the determining factors in whether an antibiotic will be prescribed and which it will be. The British National Formulary, though not fully confronting these dilemmas, advocates a conservative prescribing policy by, for example, urging that antibiotics should not be used in viral illness but when indicated should be chosen on a "best guess" basis.'3 Our survey tends to confirm the application of the British National Formulary approach as the range of antimicrobials prescribed was fairly limited. In addition, within this group five agents accounted for 70% of the total volume of prescribing for all antimicrobial preparations.
A detailed analysis of the prescribing, however, highlights several important features. Firstly, there were a number of notable changes in the relative balance ofthe choice ofagents prescribed. For example, the use of traditional tetracyclines declined in favour of the newer agents doxycycline and minocycline (fig 4) . Similarly, within the common group of antimicrobials the decrease in the amount of ampicillin and cotrimoxazole prescribed was matched by an increase in prescribing of amoxycillin and trimethoprim. Though since 1985 the use of amoxycillin has exceeded that of ampicillin in terms of standard dosing units,'7 the total amount of ampicillin prescribed was still greater than that of amoxycillin (fig 2) . The main reasons for these trends are probably the potential benefits of amoxycillin over ampicillin in achieving better blood concentrations from equivalent doses'8 and the better safety profile of trimethoprim over co-trimoxazole without any apparent compromise in clinical efficacy. 19 Within the penicillins the prescribing of phenoxymethylpenicillin and the combination of ampicillin and flucloxacillin increased by 56% from 1983 to 1987. More importantly, amoxycillin-clavulanic acid was prescribed 2-3 times more frequently in 1987 than 1983. Whether these observations suggest a shift in microbial sensitivities, aggressive marketing by the manufacturers, or a concerted effort on the part of prescribers to rationalise their choice of prescribing within the occasional group of drugs is not clear.
Secondly, though prescribers may try to limit the range of agents prescribed,20 it is important to note that those compounds which were prescribed occasionally in 1983 doubled their market position in the five years studied. This is a significant change as it represents a substantially different profile in prescribing which prompts the question of what factors influence such changes. Company marketing is undoubtedly a factor. For example, the sudden but dramatic increase in the prescribing of pivampicillin in 1987-8 after several years of declining use corresponded with concerted local promotion by the manufacturer (fig 5) .
Not only is marketing itself an important factor, so is the way in which a product is promoted. For example, any incidence of resistance can be interpreted to promote the benefits of a particular compound. Though bacterial resistance is a problem in hospital, it is not widely observed in the community and should not be given undue emphasis in the decision to use new compounds.2' Hence it may be argued that though ciprofloxacin, for example, deserves an important place in prescribing in hospital, its increased use in the community is unjustified.22 Therefore, rather than attempt to overcome or pre-empt resistance by prescribing yet another agent the objective should be to prevent resistance by limiting the amount of antibiotic prescriptions. "
The third feature illustrated by the data is the cost implication of prescribing. Though the increase in prescribing costs for antimicrobials in Northern Ireland is modest (10%) as compared with that for other therapeutic classes (33%), a notable increase in prescribing costs for antimicrobials occurred in 1987 (fig 1) . This was to be expected after the substantial increase in the use of the occasional antimicrobial group in that year (fig 4) and the generally higher cost of these agents ( 
